Oligomerization of DNMT3A Controls the Mechanism of De Novo DNA Methylation

Overview

Journal J Biol Chem

Specialty Biochemistry

Date 2011 Oct 8

PMID 21979949

Citations 37

Authors

Celeste Holz-Schietinger

Douglas M Matje

Madeleine Flexer Harrison

Norbert O Reich

Affiliations

Soon will be listed here.

Abstract

DNMT3A is one of two human de novo DNA methyltransferases essential for regulating gene expression through cellular development and differentiation. Here we describe the consequences of single amino acid mutations, including those implicated in the development of acute myeloid leukemia (AML) and myelodysplastic syndromes, at the DNMT3A·DNMT3A homotetramer and DNMT3A·DNMT3L heterotetramer interfaces. A model for the DNMT3A homotetramer was developed via computational interface scanning and tested using light scattering and electrophoretic mobility shift assays. Distinct oligomeric states were functionally characterized using fluorescence anisotropy and steady-state kinetics. Replacement of residues that result in DNMT3A dimers, including those identified in AML patients, show minor changes in methylation activity but lose the capacity for processive catalysis on multisite DNA substrates, unlike the highly processive wild-type enzyme. Our results are consistent with the bimodal distribution of DNA methylation in vivo and the loss of clustered methylation in AML patients. Tetramerization with the known interacting partner DNMT3L rescues processive catalysis, demonstrating that protein binding at the DNMT3A tetramer interface can modulate methylation patterning. Our results provide a structural mechanism for the regulation of DNMT3A activity and epigenetic imprinting.

Citing Articles

Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis.

Tan Z, Zhang X, Feng J, Zhao Y, Hu H, Wu D Ann Hematol. 2025; .

PMID: 39873798 DOI: 10.1007/s00277-024-06152-6.

Increased local DNA methylation disorder in AMLs with DNMT3A-destabilizing variants and its clinical implication.

Lee D, Koo B, Kim S, Byun J, Hong J, Shin D Nat Commun. 2025; 16(1):560.

PMID: 39794314 PMC: 11724044. DOI: 10.1038/s41467-024-55691-z.

Cancer-associated DNA hypermethylation of Polycomb targets requires DNMT3A dual recognition of histone H2AK119 ubiquitination and the nucleosome acidic patch.

Gretarsson K, Abini-Agbomson S, Gloor S, Weinberg D, McCuiston J, Kumary V Sci Adv. 2024; 10(35):eadp0975.

PMID: 39196936 PMC: 11352909. DOI: 10.1126/sciadv.adp0975.

Structural basis for the H2AK119ub1-specific DNMT3A-nucleosome interaction.

Chen X, Guo Y, Zhao T, Lu J, Fang J, Wang Y Nat Commun. 2024; 15(1):6217.

PMID: 39043678 PMC: 11266573. DOI: 10.1038/s41467-024-50526-3.

Structure-guided functional suppression of AML-associated DNMT3A hotspot mutations.

Lu J, Guo Y, Yin J, Chen J, Wang Y, Wang G Nat Commun. 2024; 15(1):3111.

PMID: 38600075 PMC: 11006857. DOI: 10.1038/s41467-024-47398-y.

References

Vilkaitis G, Suetake I, Klimasauskas S, Tajima S . Processive methylation of hemimethylated CpG sites by mouse Dnmt1 DNA methyltransferase. J Biol Chem. 2004; 280(1):64-72. DOI: 10.1074/jbc.M411126200. View

Klose R, Bird A . Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci. 2006; 31(2):89-97. DOI: 10.1016/j.tibs.2005.12.008. View

Van Emburgh B, Robertson K . Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants. Nucleic Acids Res. 2011; 39(12):4984-5002. PMC: 3130282. DOI: 10.1093/nar/gkr116. View

Kortemme T, Kim D, Baker D . Computational alanine scanning of protein-protein interfaces. Sci STKE. 2004; 2004(219):pl2. DOI: 10.1126/stke.2192004pl2. View

Li Y, Zhou P, Zheng X, Walsh C, Xu G . Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair. Nucleic Acids Res. 2006; 35(2):390-400. PMC: 1802599. DOI: 10.1093/nar/gkl1052. View

Walter M, Ding L, Shen D, Shao J, Grillot M, McLellan M . Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia. 2011; 25(7):1153-8. PMC: 3202965. DOI: 10.1038/leu.2011.44. View

Hiller D, Fogg J, Martin A, Beechem J, Reich N, Perona J . Simultaneous DNA binding and bending by EcoRV endonuclease observed by real-time fluorescence. Biochemistry. 2003; 42(49):14375-85. DOI: 10.1021/bi035520w. View

Symmons M, Jones G, Luisi B . A duplicated fold is the structural basis for polynucleotide phosphorylase catalytic activity, processivity, and regulation. Structure. 2000; 8(11):1215-26. DOI: 10.1016/s0969-2126(00)00521-9. View

Ha T, Rasnik I, Cheng W, Babcock H, Gauss G, Lohman T . Initiation and re-initiation of DNA unwinding by the Escherichia coli Rep helicase. Nature. 2002; 419(6907):638-41. DOI: 10.1038/nature01083. View

10.

Robertson K . DNA methylation and human disease. Nat Rev Genet. 2005; 6(8):597-610. DOI: 10.1038/nrg1655. View

11.

Klug M, Rehli M . Functional analysis of promoter CpG methylation using a CpG-free luciferase reporter vector. Epigenetics. 2007; 1(3):127-30. DOI: 10.4161/epi.1.3.3327. View

12.

Shieh F, Youngblood B, Reich N . The role of Arg165 towards base flipping, base stabilization and catalysis in M.HhaI. J Mol Biol. 2006; 362(3):516-27. DOI: 10.1016/j.jmb.2006.07.030. View

13.

Takeshita K, Suetake I, Yamashita E, Suga M, Narita H, Nakagawa A . Structural insight into maintenance methylation by mouse DNA methyltransferase 1 (Dnmt1). Proc Natl Acad Sci U S A. 2011; 108(22):9055-9. PMC: 3107267. DOI: 10.1073/pnas.1019629108. View

14.

Kareta M, Botello Z, Ennis J, Chou C, Chedin F . Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L. J Biol Chem. 2006; 281(36):25893-902. DOI: 10.1074/jbc.M603140200. View

15.

Hata K, Okano M, Lei H, Li E . Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development. 2002; 129(8):1983-93. DOI: 10.1242/dev.129.8.1983. View

16.

Jia D, Jurkowska R, Zhang X, Jeltsch A, Cheng X . Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature. 2007; 449(7159):248-51. PMC: 2712830. DOI: 10.1038/nature06146. View

17.

Ley T, Ding L, Walter M, McLellan M, Lamprecht T, Larson D . DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010; 363(25):2424-33. PMC: 3201818. DOI: 10.1056/NEJMoa1005143. View

18.

Hervouet E, Vallette F, Cartron P . Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics. 2009; 4(7):487-99. DOI: 10.4161/epi.4.7.9883. View

19.

Matje D, Coughlin D, Connolly B, Dahlquist F, Reich N . Determinants of precatalytic conformational transitions in the DNA cytosine methyltransferase M.HhaI. Biochemistry. 2011; 50(9):1465-73. DOI: 10.1021/bi101446g. View

20.

Sharma V, Youngblood B, Reich N . Residues distal from the active site that alter enzyme function in M.HhaI DNA cytosine methyltransferase. J Biomol Struct Dyn. 2005; 22(5):533-43. DOI: 10.1080/07391102.2005.10507023. View